Reix, Philippe
2 papers on CoChatORCID 0000-0002-9192-8335
Most cited papers
- Verified
Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
Flume, P. A., Biner, R. F., Downey, D. G., Brown, C., Jain, M., Fischer, R., De Boeck, K., Sawicki, G. S., Chang, P., Paz-Diaz, H., et al. (2021) · The Lancet Respiratory Medicine
Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery
Cited by 52
- Verified
Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
Mainguy, C., Bellon, G., Delaup, V., Ginoux, T., Kassai-Koupai, B., Mazur, S., Rabilloud, M., Remontet, L., & Reix, P. (2017) · Journal of Pediatric Endocrinology and Metabolism
Cystic Fibrosis Research AdvancesDiabetes Management and Research
Cited by 37
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free